Kintor Pharmaceutical Limited
Kintor Pharmaceutical Limited (KNTPF) Revenue
Annual & quarterly revenue history · segment & region breakdown
KNTPF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsKintor Pharmaceutical Limited trailing twelve-month (TTM) revenue is $0.03B, an increase of 536.77% year-over-year from $0.03B in FY2025.
Revenue trend
2025 – 2014 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.03B | +$0.03B | +536.77% |
| 2024-12-31 | $0.01B | +$0.01B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | -$0.03B | -100.00% |
| 2021-12-31 | $0.03B | +$0.03B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | -$0.00B | -100.00% |
| 2018-12-31 | $0.00B | -$0.00B | -99.86% |
| 2017-12-31 | $0.00B | -$0.00B | -66.41% |
| 2016-12-31 | $0.00B | +$0.00B | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Kintor Pharmaceutical Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Kintor Pharmaceutical Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CNY.
Data sourced from Kintor Pharmaceutical Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
KNTPF revenue · 4 questionsKNTPF's trailing twelve-month (TTM) revenue is $0.03B. That is an increase of 536.77% year-over-year from $0.03B in FY2025.
▸ Source: FMP · Kintor Pharmaceutical Limited SEC filings · GAAP · Kintor Pharmaceutical Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026